Skip to main content
H

HeartKinetics

HeartKinetics develops AI-driven solutions that utilize motion and ECG wearable sensors to detect heart failure and monitor cardiotoxicity in cancer patients. This technology enables early intervention and personalized care, improving patient outcomes in critical health conditions.

Founded 201931K+ followers
Updated 4 months ago

Funding

$540.2K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Heart failure often goes undetected until it reaches advanced stages, leading to poor patient outcomes and increased healthcare costs. Existing methods for monitoring cardiotoxicity in cancer patients, a common side effect of chemotherapy, are often invasive, expensive, and require specialized equipment. Continuous, non-invasive monitoring solutions are needed to enable early detection and intervention for these critical cardiac conditions.

Solution

HeartKinetics provides an AI-powered platform that leverages motion and ECG data from wearable sensors to detect heart failure and monitor cardiotoxicity. The system analyzes subtle changes in a patient's movement and cardiac signals to identify early warning signs of cardiac dysfunction. By continuously monitoring patients in their daily lives, HeartKinetics enables timely intervention and personalized care plans. The platform's algorithms provide clinicians with actionable insights, facilitating proactive management of heart failure and chemotherapy-induced cardiotoxicity.

Target Audience

The primary target audience includes cardiologists, oncologists, and other healthcare providers involved in the management of heart failure and cancer patients at risk of cardiotoxicity, as well as hospitals and remote patient monitoring programs.

Features

  • Continuous monitoring of ECG and motion data via wearable sensors
  • AI-powered algorithms for early detection of heart failure and cardiotoxicity
  • Real-time alerts and notifications for clinicians based on patient-specific risk profiles
  • Secure cloud-based platform for data storage and analysis
  • Integration with existing electronic health record (EHR) systems
  • Remote patient monitoring capabilities for improved access to care
  • Personalized risk assessment and treatment recommendations
  • Support for various wearable sensor devices
This profile is AI-generated and may contain inaccuracies.